Abstract
Thalidomide has been used as a treatment for various human immunodeficiency virus (HIV)-associated and non-HIV-associated illnesses, generally in cases in which inflammatory disease is refractory to standard therapy. Here, we discuss the successful use of thalidomide in 3 patients with severe, idiopathic HIV-associated colitis. © 2008 by the Infectious Diseases Society of America. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 133-136 |
| Number of pages | 3 |
| Journal | Clinical Infectious Diseases |
| Volume | 47 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jul 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adult
- drug therapy: Colitis
- pathology: Colon
- Colonoscopy
- complications: HIV Infections
- Humans
- therapeutic use: Immunosuppressive Agents
- pathology: Intestinal Mucosa
- Male
- Middle Aged
- therapeutic use: Thalidomide
- Treatment Outcome
Fingerprint
Dive into the research topics of 'Thalidomide treatment for refractory HIV-associated colitis: A case series'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver